|
000
| 02238nam 2200337zi 4500 |
|---|
| 001 | 9.933620 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240222132827 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 240207e202203 oncad o f000 0 eng d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-224/2022E-PDF |
|---|
| 245 | 00|aEvaluation of the Human Pathogens and Toxins Act and regulations framework, 2015-16 to 2020-21 / |cprepared by the Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. |
|---|
| 264 | 1|a[Ottawa] : |bHealth Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, |cMarch 2022. |
|---|
| 300 | |a1 online resource (27 pages) : |bgraphs, illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Évaluation de la Loi sur les agents pathogènes humains et les toxines et de son règlement d’application, 2015-2016 à 2020-2021. |
|---|
| 520 | |a"This report presents findings from the Evaluation of the Human Pathogens and Toxins Act and Regulations (HPTAR). The evaluation is focused primarily on issues of effectiveness and efficiency, and covered activities related to the implementation of the HPTAR for the period from 2015-16 to 2020-21"--Executive summary, page ii. |
|---|
| 610 | 20|aPublic Health Agency of Canada|xEvaluation. |
|---|
| 650 | 0|aPathogenic microorganisms|zCanada|xSafety measures|xEvaluation. |
|---|
| 650 | 0|aToxins|zCanada|xSafety measures|xEvaluation. |
|---|
| 710 | 1 |aCanada. |bHealth Canada, |eissuing body. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tÉvaluation de la Loi sur les agents pathogènes humains et les toxines et de son règlement d’application, 2015-2016 à 2020-2021 / |w(CaOODSP)9.934359 |
|---|
| 856 | 40|qPDF|s671 KB|uhttps://publications.gc.ca/collections/collection_2024/aspc-phac/HP5-224-2022-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/corporate/transparency/corporate-management-reporting/evaluation/human-pathogens-toxins-act-regulations-framework-2015-2016-2020-2021.html |
|---|